Careers  |  Sign In  |  Register

Latest in Dermatology

Reuters Health • The Doctor's Channel Daily Newscast

Cases of leukoencephalopathy associated with rituximab therapy

NEW YORK (Reuters Health) - Rituximab (Rituxan) has been implicated in 57 cases of progressive multifocal leukoencephalopathy (PML) in HIV-negative patients diagnosed with hematologic malignancies or autoimmune diseases, since the drug was approved by the US Food and Drug Administration in 1997 until the...

Reuters Health • The Doctor's Channel Daily Newscast

Anti-TNF therapy ups antioxidant effect of HDL cholesterol

NEW YORK (Reuters Health) – In a small study of rheumatoid arthritis patients, treatment with the anti-tumor necrosis factor (anti-TNF) agent infliximab appeared to increase the antioxidative capacity of HDL cholesterol. This finding may help explain prior reports suggesting a cardioprotective effect...

Reuters Health • The Doctor's Channel Daily Newscast

Pegylation does not improve tolerability of interferon alpha-2b for melanoma

NEW YORK (Reuters Health) - Long-term adjuvant therapy with pegylated interferon alfa-2b (PEG-IFN-alpha-2b) for advanced melanoma improves recurrence-free survival, investigators report in an early online release from the Journal of Clinical Oncology. However, results of their large phase III trial...